Vancouver, BC – GenXys Healthcare Systems Inc. (GenXys) is adding a new value dimension to Precision Genetics and the personalized health marketplace. Precision prescribing has become a leading method to bring pharmacogenetics (PGx) closer to the standard of care for certain…
All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Osteoporosis. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions. Post-Myocardial Infarction This update includes recommendations from…
Top Five Questions and Answers from Canada’s ‘Godfather’ of Life Sciences, Dr. Pieter Cullis You’ve been on the cutting edge of life sciences for many years in taking the ‘lab to the bedside’ to improve health – can you tell us…
All TreatGx users now have access to the updated treatment algorithm for Diabetes Mellitus Type 2. Diabetes Mellitus Type 2 This comprehensive update accounts for revisions made to existing clinical guidelines that will help health care providers select the safest and most effective medications with their…
Earlier this year, I decided to take the plunge and join the board of GenXys Health Care Systems (GenXys) as an independent board member. I have been intrigued by precision medicine for years, wondering why this has been historically slow to…
Vancouver, BC – GenXys Health Care Systems (GenXys), the award-winning precision prescribing company, today announced a partnership with Helix, a leading population genomics company working at the intersection of clinical care, research, and genomics. Together, the companies will be working to…